Metabolomic screening of pre-diagnostic serum samples identifies association between α- and ?-tocopherols and glioblastoma risk

Oncotarget

Volumn 7, Issue 24, 2016, Pages 37043-37053

  Björkblom, Benny ^a   Wibom, Carl ^a   Jonsson, Pär ^a   Mörén, Lina ^a   Andersson, Ulrika ^a   Johannesen, Tom Børge ^b   Langseth, Hilde ^b   Antti, Henrik ^a   Melin, Beatrice ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b CANCER REGISTRY OF NORWAY   (Norway)

Author keywords

Antioxidants; Brain tumor; Population based; Serum metabolite; Vitamin E

Indexed keywords

2 KETO GLUCONIC ACID; ALPHA TOCOPHEROL; BIOLOGICAL MARKER; CYSTINE; ERYTHRITOL; GAMMA TOCOPHEROL; HYPOXANTHINE; INOSITOL; UNCLASSIFIED DRUG; XANTHINE; XYLOSE; TUMOR MARKER;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER DIAGNOSIS; CANCER RISK; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLITE; METABOLOMICS; OXIDATIVE STRESS; VITAMIN BLOOD LEVEL; YOUNG ADULT; BLOOD; BRAIN TUMOR; CASE CONTROL STUDY; MIDDLE AGED; OXIDATION REDUCTION REACTION; PROCEDURES;

ADULT; ALPHA-TOCOPHEROL; BIOMARKERS, TUMOR; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GAMMA-TOCOPHEROL; GLIOBLASTOMA; HUMANS; MALE; METABOLOMICS; MIDDLE AGED; OXIDATION-REDUCTION;

EID: 84978173673     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.9242     Document Type: Article

References (51)

1. Mandelzweig L, Novikov I and Sadetzki S. Smoking and risk of glioma: a meta-analysis. Cancer causes & control. 2009; 20:1927-1938.
2. Bondy ML, Scheurer ME, Malmer B, Barnholtz-Sloan JS, Davis FG, Il'yasova D, Kruchko C, McCarthy BJ, Rajaraman P, Schwartzbaum JA, Sadetzki S, Schlehofer B, Tihan T, Wiemels JL, Wrensch M, Buffler PA, et al. Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer. 2008; 113:1953-1968.
3. Schlehofer B, Blettner M, Preston-Martin S, NiehoffD, Wahrendorf J, Arslan A, Ahlbom A, Choi WN, Giles GG, Howe GR, Little J, Menegoz F and Ryan P. Role of medical history in brain tumour development. Results from the international adult brain tumour study. International journal of cancer. 1999; 82:155-160.
4. Wigertz A, Lonn S, Schwartzbaum J, Hall P, Auvinen A, Christensen HC, Johansen C, Klaeboe L, Salminen T, Schoemaker MJ, Swerdlow AJ, Tynes T and Feychting M. Allergic conditions and brain tumor risk. American journal of epidemiology. 2007; 166:941-950.
5. Lachance DH, Yang P, Johnson DR, Decker PA, Kollmeyer TM, McCoy LS, Rice T, Xiao Y, Ali-Osman F, Wang F, Stoddard SM, Sprau DJ, Kosel ML, Wiencke JK, Wiemels JL, Patoka JS, et al. Associations of high-grade glioma with glioma risk alleles and histories of allergy and smoking. American journal of epidemiology. 2011; 174:574-581.
6. Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, Malmer B, Simon M, Marie Y, Boisselier B, Delattre JY, Hoang-Xuan K, El Hallani S, Idbaih A, Zelenika D, Andersson U, Henriksson R, et al. Genome-wide association study identifies five susceptibility loci for glioma. Nature genetics. 2009; 41:899-904.
7. Brennan CW, Verhaak RG, McKenna A, Campos B, Noushmehr H, Salama SR, Zheng S, Chakravarty D, Sanborn JZ, Berman SH, Beroukhim R, Bernard B, Wu CJ, Genovese G, Shmulevich I, Barnholtz-Sloan J, et al. The somatic genomic landscape of glioblastoma. Cell. 2013; 155:462-477.
8. Melin B and Jenkins R. Genetics in glioma: lessons learned from genome-wide association studies. Current opinion in neurology. 2013; 26:688-692.
9. Jenkins RB, Xiao Y, Sicotte H, Decker PA, Kollmeyer TM, Hansen HM, Kosel ML, Zheng S, Walsh KM, Rice T, Bracci P, McCoy LS, Smirnov I, Patoka JS, Hsuang G, Wiemels JL, et al. A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutation. Nature genetics. 2012; 44:1122-1125.
10. Reitman ZJ, Jin G, Karoly ED, Spasojevic I, Yang J, Kinzler KW, He Y, Bigner DD, Vogelstein B and Yan H. Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome. Proceedings of the National Academy of Sciences of the United States of America. 2011; 108:3270-3275.
11. Benjamini Y and Hochberg Y. Controlling the False Discovery Rate-a Practical and Powerful Approach to Multiple Testing. J Roy Stat Soc B Met. 1995; 57:289-300.
12. Qin S, Wang M, Zhang T and Zhang S. Vitamin E intake is not associated with glioma risk: evidence from a metaanalysis. Neuroepidemiology. 2014; 43:253-258.
13. Dubrow R, Darefsky AS, Park Y, Mayne ST, Moore SC, Kilfoy B, Cross AJ, Sinha R, Hollenbeck AR, Schatzkin A and Ward MH. Dietary components related to N-nitroso compound formation: a prospective study of adult glioma. Cancer epidemiology, biomarkers & prevention. 2010; 19:1709-1722.
14. Michaud DS, Holick CN, Batchelor TT, Giovannucci E and Hunter DJ. Prospective study of meat intake and dietary nitrates, nitrites, and nitrosamines and risk of adult glioma. The American journal of clinical nutrition. 2009; 90:570-577.
15. Parker RS, Sontag TJ, Swanson JE and McCormick CC. Discovery, characterization, and significance of the cytochrome P450 omega-hydroxylase pathway of vitamin E catabolism. Annals of the New York Academy of Sciences. 2004; 1031:13-21.
16. ATBC-study-group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The New England journal of medicine. 1994; 330:1029-1035.
17. Klein EA, Thompson IM, Jr., Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, Minasian LM, Ford LG, Parnes HL, Gaziano JM, Karp DD, Lieber MM, Walther PJ, Klotz L, Parsons JK, Chin JL, et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Jama. 2011; 306:1549-1556.
18. WikoffWR, Grapov D, Fahrmann JF, DeFelice B, Rom WN, Pass HI, Kim K, Nguyen U, Taylor SL, Gandara DR, Kelly K, Fiehn O and Miyamoto S. Metabolomic markers of altered nucleotide metabolism in early stage adenocarcinoma. Cancer prevention research. 2015; 8:410-418.
19. Schlehofer B, Siegmund B, Linseisen J, Schuz J, Rohrmann S, Becker S, Michaud D, Melin B, Bas Bueno-de-Mesquita H, Peeters PH, Vineis P, Tjonneland A, Olsen A, Overvad K, Romieu I, Boeing H, et al. Primary brain tumours and specific serum immunoglobulin E: a case-control study nested in the European Prospective Investigation into Cancer and Nutrition cohort. Allergy. 2011; 66:1434-1441.
20. Schwartzbaum J, Ding B, Johannesen TB, Osnes LT, Karavodin L, Ahlbom A, Feychting M and Grimsrud TK. Association between prediagnostic IgE levels and risk of glioma. Journal of the National Cancer Institute. 2012; 104:1251-1259.
21. Jiang Q. Natural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy. Free radical biology & medicine. 2014; 72:76-90.
22. Jiang Q, Yin X, Lill MA, Danielson ML, Freiser H and Huang J. Long-chain carboxychromanols, metabolites of vitamin E, are potent inhibitors of cyclooxygenases. Proceedings of the National Academy of Sciences of the United States of America. 2008; 105:20464-20469.
23. Betti M, Minelli A, Ambrogini P, Ciuffoli S, Viola V, Galli F, Canonico B, Lattanzi D, Colombo E, Sestili P and Cuppini R. Dietary supplementation with alpha-tocopherol reduces neuroinflammation and neuronal degeneration in the rat brain after kainic acid-induced status epilepticus. Free radical research. 2011; 45:1136-1142.
24. Wagner JG, Harkema JR, Jiang Q, Illek B, Ames BN and Peden DB. Gamma-tocopherol attenuates ozone-induced exacerbation of allergic rhinosinusitis in rats. Toxicologic pathology. 2009; 37:481-491.
25. Jiang Q and Ames BN. Gamma-tocopherol, but not alpha-tocopherol, decreases proinflammatory eicosanoids and inflammation damage in rats. FASEB journal. 2003; 17:816-822.
26. Abdala-Valencia H, Berdnikovs S and Cook-Mills JM. Vitamin E isoforms as modulators of lung inflammation. Nutrients. 2013; 5:4347-4363.
27. Sayin VI, Ibrahim MX, Larsson E, Nilsson JA, Lindahl P and Bergo MO. Antioxidants accelerate lung cancer progression in mice. Science translational medicine. 2014; 6:221ra215.
28. Le Gal K, Ibrahim MX, Wiel C, Sayin VI, Akula MK, Karlsson C, Dalin MG, Akyurek LM, Lindahl P, Nilsson J and Bergo MO. Antioxidants can increase melanoma metastasis in mice. Science translational medicine. 2015; 7:308re308.
29. Slyskova J, Lorenzo Y, Karlsen A, Carlsen MH, Novosadova V, BlomhoffR, Vodicka P and Collins AR. Both genetic and dietary factors underlie individual differences in DNA damage levels and DNA repair capacity. DNA repair. 2014; 16:66-73.
30. Wang X, Ni J, Hsu CL, Johnykutty S, Tang P, Ho YS, Lee CH and Yeh S. Reduced expression of tocopherolassociated protein (TAP/Sec14L2) in human breast cancer. Cancer investigation. 2009; 27:971-977.
31. Tam KW, Ho CT, Lee WJ, Tu SH, Huang CS, Chen CS, Lee CH, Wu CH and Ho YS. Alteration of alphatocopherol-associated protein (TAP) expression in human breast epithelial cells during breast cancer development. Food chemistry. 2013; 138:1015-1021.
32. Kempna P, Zingg JM, Ricciarelli R, Hierl M, Saxena S and Azzi A. Cloning of novel human SEC14p-like proteins: ligand binding and functional properties. Free radical biology & medicine. 2003; 34:1458-1472.
33. Bleeker FE, Lamba S, Zanon C, Molenaar RJ, Hulsebos TJ, Troost D, van Tilborg AA, Vandertop WP, Leenstra S, van Noorden CJ and Bardelli A. Mutational profiling of kinases in glioblastoma. BMC cancer. 2014; 14:718.
34. Gadoth N and Goebel HH. (2011). Oxidative stress and free radical damage in neurology. (New York: Humana Press).
35. den Hartog GJ, Boots AW, Adam-Perrot A, Brouns F, Verkooijen IW, Weseler AR, Haenen GR and Bast A. Erythritol is a sweet antioxidant. Nutrition. 2010; 26:449-458.
36. Jahn M, Baynes JW and Spiteller G. The reaction of hyaluronic acid and its monomers, glucuronic acid and N-acetylglucosamine, with reactive oxygen species. Carbohydrate research. 1999; 321:228-234.
37. Verhoeven NM, Huck JH, Roos B, Struys EA, Salomons GS, Douwes AC, van der Knaap MS and Jakobs C. Transaldolase deficiency: liver cirrhosis associated with a new inborn error in the pentose phosphate pathway. American journal of human genetics. 2001; 68:1086-1092.
38. Eyaid W, Al Harbi T, Anazi S, Wamelink MM, Jakobs C, Al Salammah M, Al Balwi M, Alfadhel M and Alkuraya FS. Transaldolase deficiency: report of 12 new cases and further delineation of the phenotype. Journal of inherited metabolic disease. 2013; 36:997-1004.
39. Jiang WD, Kuang SY, Liu Y, Jiang J, Hu K, Li SH, Tang L, Feng L and Zhou XQ. Effects of myo-inositol on proliferation, differentiation, oxidative status and antioxidant capacity of carp enterocytes in primary culture. Aquacult Nutr. 2013; 19:45-53.
40. Wibom C, Surowiec I, Moren L, Bergstrom P, Johansson M, Antti H and Bergenheim AT. Metabolomic patterns in glioblastoma and changes during radiotherapy: a clinical microdialysis study. Journal of proteome research. 2010; 9:2909-2919.
41. Moren L, Bergenheim AT, Ghasimi S, Brannstrom T, Johansson M and Antti H. Metabolomic Screening of Tumor Tissue and Serum in Glioma Patients Reveals Diagnostic and Prognostic Information. Metabolites. 2015; 5:502-520.
42. Ichida K, Amaya Y, Okamoto K and Nishino T. Mutations associated with functional disorder of xanthine oxidoreductase and hereditary xanthinuria in humans. International journal of molecular sciences. 2012; 13:15475-15495.
43. Kudo M, Moteki T, Sasaki T, Konno Y, Ujiie S, Onose A, Mizugaki M, Ishikawa M and Hiratsuka M. Functional characterization of human xanthine oxidase allelic variants. Pharmacogenetics and genomics. 2008; 18:243-251.
44. Kokoglu E, Belce A, Ozyurt E and Tepeler Z. Xanthine oxidase levels in human brain tumors. Cancer letters. 1990; 50:179-181.
45. Langseth H, Gislefoss RE, Martinsen JI, Dillner J and Ursin G. Cohort Profile: The Janus Serum Bank Cohort in Norway. International journal of epidemiology. 2016. Apr 10. pii: dyw027. [Epub ahead of print]. doi: 10.1093/ije/dyw027.
46. Larsen IK, Smastuen M, Johannesen TB, Langmark F, Parkin DM, Bray F and Moller B. Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. European journal of cancer. 2009; 45:1218-1231.
47. Gislefoss RE, Grimsrud TK and Morkrid L. Longterm stability of serum components in the Janus Serum Bank. Scandinavian journal of clinical and laboratory investigation. 2008; 68:402-409.
48. Jonsson P, Wuolikainen A, Thysell E, Chorell E, Stattin P, Wikstrom P and Antti H. Constrained randomization and multivariate effect projections improve information extraction and biomarker pattern discovery in metabolomics studies involving dependent samples. Metabolomics. 2015; 11:1667-1678.
49. Jonsson P, Johansson ES, Wuolikainen A, Lindberg J, Schuppe-Koistinen I, Kusano M, Sjostrom M, Trygg J, Moritz T and Antti H. Predictive metabolite profiling applying hierarchical multivariate curve resolution to GC-MS data- a potential tool for multi-parametric diagnosis. Journal of proteome research. 2006; 5:1407-1414.
50. Wold S, Johansson E and Cocchi M. (1993). PLS-partial leastsquares projections to latent structures. In: Kubinyi H, ed. 3D QSAR in Drug Design, Theory Methods and Applications. (Leiden: ESCOM Science Publishers), pp. 523-550.
51. Eriksson L, Trygg J and Wold S. CV-ANOVA for significance testing of PLS and OPLS (R) models. J Chemometr. 2008; 22:594-600.